Advertisement

Index by author

April 01, 1997; Volume 281,Issue 1

  1. Aurang, K.

    1. Somatostatin Inhibition of Acid and Histamine Release by Activation of Somatostatin Receptor Subtype 2 Receptors in Rats
      K. Aurang, J. Wang and K. C. K. Lloyd
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 245-252;

  2. Baghdoyan, H. A.

    1. M2, M3 and M4, but not M1, Muscarinic Receptor Subtypes are Present in Rat Spinal Cord
      A. U. Höglund and H. A. Baghdoyan
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 470-477;

  3. Baird, Anne J.

    1. Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448
      Allen W. Gomoll, Russell A. Roth, Robert E. Swillo, Anne J. Baird, Carol S. Sargent, Ronald W. Behling, Harold J. Malone and Gary J. Grover
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 24-33;

  4. Bally, Marcel B.

    1. Influence of Drug Release Characteristics on the Therapeutic Activity of Liposomal Mitoxantrone
      Howard J. Lim, Dana Masin, Thomas D. Madden and Marcel B. Bally
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 566-573;

  5. Baylon, Godofredo J.

    1. Inhibition of Cytochrome P450 2D6 Metabolism of Hydrocodone to Hydromorphone Does Not Importantly Affect Abuse Liability
      Howard L. Kaplan, Usoa E. Busto, Godofredo J. Baylon, Siu W. Cheung, S. Victoria Otton, Gail Somer and Edward M. Sellers
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 103-108;

  6. Beaty, Timothy M.

    1. Hepatobiliary Excretion of Bile Acids and Rose Bengal in Streptozotocin-Induced and Genetic Diabetic Rats
      Joy L. Stone, Joel B. Braunstein, Timothy M. Beaty, Ruth A. Sanders and John B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 412-419;

  7. Beck, Sheryl G.

    1. Fluoxetine Selectively Alters 5-Hydroxytryptamine1Aand γ-Aminobutyric AcidB Receptor-Mediated Hyperpolarization in Area CA1, but not Area CA3, Hippocampal Pyramidal Cells
      Sheryl G. Beck, Susanne Birnstiel, Kue C. Choi and Wendy A. Pouliot
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 115-122;

  8. Beck, Terry

    1. Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice
      Florence I. Raynaud, Rosanne M. Orr, Phyllis M. Goddard, Heidi A. Lacey, Helen Lancashire, Ian R. Judson, Terry Beck, Bob Bryan and Finbarr E. Cotter
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 420-427;

  9. Behling, Ronald W.

    1. Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448
      Allen W. Gomoll, Russell A. Roth, Robert E. Swillo, Anne J. Baird, Carol S. Sargent, Ronald W. Behling, Harold J. Malone and Gary J. Grover
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 24-33;

  10. Berlin, K. Darrell

    1. Class III Electrophysiologic Actions of Imidazole-Substituted Diheterabicyclononanes in Canine Myocardium
      Eugene Patterson, Benjamin J. Scherlag, Subiah Sangiah, Gregory L. Garrison, Kevin M. Couch, K. Darrell Berlin and Ralph Lazzara
      Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 155-162;
« Previous (Pages : 1 2 3 4 5 6 7 ... 33) Next »
Back to top

In this issue

Advertisement